Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer
暂无分享,去创建一个
[1] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[2] Jiayi Wang,et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer , 2010, Nucleic acids research.
[3] N. Rajewsky,et al. The evolution of gene regulation by transcription factors and microRNAs , 2007, Nature Reviews Genetics.
[4] N. Stanietsky,et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity , 2009, Proceedings of the National Academy of Sciences.
[5] F. D. D. Fagagna. Living on a break: cellular senescence as a DNA-damage response , 2008, Nature Reviews Cancer.
[6] Leonard Lipovich,et al. MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. , 2010, Biochimica et biophysica acta.
[7] J. Rinn,et al. lincRNAs act in the circuitry controlling pluripotency and differentiation , 2011, Nature.
[8] D. Bartel,et al. lincRNAs: Genomics, Evolution, and Mechanisms , 2013, Cell.
[9] T. Kwok,et al. Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR. , 2007, RNA.
[10] E. Sotillo,et al. The long reach of noncoding RNAs , 2011, Nature Genetics.
[11] H. Xiao,et al. Genome-wide analysis of microRNA and mRNA expression signatures in hydroxycamptothecin-resistant gastric cancer cells , 2011, Acta Pharmacologica Sinica.
[12] J. Settleman,et al. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.
[13] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Hou,et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. , 2013, The Journal of urology.
[15] Sergio Verjovski-Almeida,et al. Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer , 2004, Oncogene.
[16] Ru Cheng,et al. Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. , 2009, Angewandte Chemie.
[17] S. Diederichs,et al. Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. , 2011, Genome research.
[18] R. Tukey,et al. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. , 2000, Annual review of pharmacology and toxicology.
[19] R. Hoffman,et al. Hematology: Basic Principles and Practice , 1995 .
[20] C. Ponting,et al. Evolution and Functions of Long Noncoding RNAs , 2009, Cell.
[21] A. Jemal,et al. Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.
[22] L. Staudt,et al. Stromal gene signatures in large-B-cell lymphomas. , 2008, The New England journal of medicine.
[23] Charles P. Lin,et al. MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. , 2009, Blood.
[24] Randeep Rakwal,et al. MALAT‐1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility‐related genes , 2010, FEBS letters.
[25] K. Zatloukal,et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. , 2007, Gastroenterology.
[26] William Stafford Noble,et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.
[27] D. Lamm,et al. Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. , 2008, The Journal of urology.
[28] P. Rothberg,et al. Oncogenes and cancer. , 1983, Cancer investigation.
[29] Howard Y. Chang,et al. Extensive and coordinated transcription of noncoding RNAs within cell cycle promoters , 2011, Nature Genetics.
[30] Benjamin D Smith,et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] A. Calcagno,et al. ABC drug transporters as molecular targets for the prevention of multidrug resistance and drug-drug interactions. , 2007, Current drug delivery.
[32] Z. Kiss-László,et al. Sequence and structural elements of methylation guide snoRNAs essential for site‐specific ribose methylation of pre‐rRNA , 1998, The EMBO journal.
[33] C. Bennett,et al. Providing cancer care to a graying and diverse cancer population in the 21st century: are we prepared? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] Jeannie T. Lee. Epigenetic Regulation by Long Noncoding RNAs , 2012, Science.
[35] T. Kwok,et al. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells , 2007, Oncogene.
[36] Michael R Hamblin,et al. CA : A Cancer Journal for Clinicians , 2011 .
[37] T. Clozel,et al. Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma. , 2013, Cancer discovery.
[38] M. Gottesman,et al. Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.
[39] A. Petherick. Genetics: The production line , 2008, Nature.
[40] E. Malek,et al. MicroRNAs in Brain Metastases: Potential Role as Diagnostics and Therapeutics , 2014, International journal of molecular sciences.
[41] L. Staudt,et al. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. , 2009, Blood.
[42] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[43] K. Morris,et al. Perspectives on the mechanism of transcriptional regulation by long non-coding RNAs , 2014, Epigenetics.
[44] Brad A Chapman,et al. The genomic binding sites of a noncoding RNA , 2011, Proceedings of the National Academy of Sciences.
[45] P. Gobbi,et al. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] P. Stadler,et al. RNA Maps Reveal New RNA Classes and a Possible Function for Pervasive Transcription , 2007, Science.
[47] N. Tran,et al. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. , 2006, DNA and cell biology.
[48] M. Baker. Long noncoding RNAs: the search for function , 2011, Nature Methods.
[49] A. Kong,et al. Induction of phase I, II and III drug metabolism/transport by xenobiotics , 2005, Archives of pharmacal research.
[50] A. Hochberg,et al. Use of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic Cancer , 2010, Journal of oncology.
[51] John N. Hutchinson,et al. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains , 2007, BMC Genomics.
[52] P. Fraser,et al. No-Nonsense Functions for Long Noncoding RNAs , 2011, Cell.
[53] Danny Reinberg,et al. Molecular Signals of Epigenetic States , 2010, Science.
[54] M. Gottesman,et al. Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.
[55] J. Rinn,et al. Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination , 2013, Nature Communications.
[56] Bruce Goldman,et al. Multidrug resistance: can new drugs help chemotherapy score against cancer? , 2003, Journal of the National Cancer Institute.
[57] N. Skoetz,et al. Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma , 2007, The Cochrane database of systematic reviews.
[58] B. Rollins,et al. microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia. , 2009, Blood.
[59] L. Harries,et al. Long non-coding RNAs and human disease. , 2012, Biochemical Society transactions.
[60] G. Calin,et al. Non‐coding RNAs as theranostics in human cancers , 2012, Journal of cellular biochemistry.
[61] R. Spizzo,et al. Long non-coding RNAs and cancer: a new frontier of translational research? , 2012, Oncogene.
[62] Tyler Risom,et al. Evolutionary conservation of microRNA regulatory circuits: an examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny. , 2007, DNA and cell biology.
[63] Wei Gao,et al. Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[64] A. Hüttenhofer,et al. The expanding snoRNA world. , 2002, Biochimie.
[65] R. Weinberg,et al. The Biology of Cancer , 2006 .
[66] J. Chi,et al. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival , 2011, Biology Direct.
[67] Howard Y. Chang,et al. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.
[68] Emily A. Vucic,et al. Human Cancer Long Non-Coding RNA Transcriptomes , 2011, PloS one.
[69] Xiaobing Fu,et al. Long Noncoding RNAs: Insights from Biological Features and Functions to Diseases , 2013, Medicinal research reviews.
[70] A. Bouchie. First microRNA mimic enters clinic , 2013, Nature Biotechnology.
[71] S. Liao,et al. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[72] Kevin V. Morris,et al. Non-coding RNAs and epigenetic regulation of gene expression : drivers of natural selection , 2012 .
[73] Chen Yang,et al. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. , 2012, International journal of oncology.
[74] R. Aharonov,et al. Identification of hundreds of conserved and nonconserved human microRNAs , 2005, Nature Genetics.
[75] Toshiro K. Ohsumi,et al. Genome-wide identification of polycomb-associated RNAs by RIP-seq. , 2010, Molecular cell.
[76] H. Gronemeyer,et al. Towards novel paradigms for cancer therapy , 2011, Oncogene.
[77] Michael M Gottesman,et al. Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes , 2012, Pharmacological Reviews.
[78] Wolfgang A. Weber,et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.
[79] Leonard Lipovich,et al. Erratum to "MacroRNA underdogs in a microRNA world: Evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA" [Biochem. Biophys. Acta 1799 (2010) 597-615] , 2011 .
[80] Thomas D. Schmittgen,et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. , 2007, Cancer cell.
[81] H. Pass,et al. Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies. , 2008, Future oncology.
[82] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[83] George A. Calin,et al. MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.
[84] C. Aghajanian,et al. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group. , 2004, Gynecologic oncology.
[85] G. Chrousos,et al. Noncoding RNA Gas5 Is a Growth Arrest– and Starvation-Associated Repressor of the Glucocorticoid Receptor , 2010, Science Signaling.
[86] J. Hou,et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. , 2013, European journal of cancer.
[87] Howard Y. Chang,et al. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. , 2011, Molecular cell.
[88] C. Croce. Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.
[89] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[90] Abraham Hochberg,et al. Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences , 2010, Journal of Translational Medicine.
[91] L. Doyle,et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[92] David Penny,et al. Relics from the RNA World , 1998, Journal of Molecular Evolution.
[93] Mathew W. Wright,et al. Naming 'junk': Human non-protein coding RNA (ncRNA) gene nomenclature , 2011, Human Genomics.
[94] Howard Y. Chang,et al. Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.
[95] I. Weissman,et al. Therapeutic implications of cancer stem cells. , 2004, Current opinion in genetics & development.
[96] J. Rinn,et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression , 2009, Proceedings of the National Academy of Sciences.
[97] A. Bader,et al. Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo , 2012, Leukemia.
[98] Michael Thomas,et al. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.
[99] Robert N. Anderson,et al. Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels , 2013, Journal of the National Cancer Institute.
[100] M. Esteller. Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.
[101] Howard Y. Chang,et al. Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.
[102] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[103] T. Litman,et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. , 1999, Cancer research.
[104] A. Hüttenhofer,et al. Non-coding RNAs: hope or hype? , 2005, Trends in genetics : TIG.
[105] M. Ingelman-Sundberg,et al. Epigenomics and Interindividual Differences in Drug Response , 2012, Clinical pharmacology and therapeutics.
[106] D. Ekwueme,et al. Economic burden of cancer survivorship among adults in the United States. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[107] Jiajia Wang,et al. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. , 2010, Acta biochimica et biophysica Sinica.
[108] Yang Liu,et al. In vivo delivery of RNAi with lipid-based nanoparticles. , 2011, Annual review of biomedical engineering.
[109] Yong Yang,et al. The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell , 2013, PloS one.
[110] B. Bao,et al. Targeting CSC-related miRNAs for cancer therapy by natural agents. , 2012, Current drug targets.
[111] C. Sherr,et al. Principles of Tumor Suppression , 2004, Cell.
[112] Melanie A. Huntley,et al. Evolution of genes and genomes on the Drosophila phylogeny , 2007, Nature.
[113] Howard Y. Chang,et al. Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes , 2010, Science.
[114] A. Jemal,et al. Global Cancer Statistics , 2011 .
[115] I. Cascorbi,et al. miRNAs as mediators of drug resistance. , 2012, Epigenomics.
[116] E. Anaissie,et al. MicroRNA theragnostics for the clinical management of multiple myeloma , 2014, Leukemia.
[117] Howard Y. Chang,et al. Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.